Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Roma AA, Goyal A, Yang B. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions. Int J Gynecol Pathol. 2015;34(5):480-6.

Alinari L, Mahasenan KV, Yan F, Karkhanis V, Chung J-, Smith EM, et al. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. Blood. 2015;125(16):2530-43.

Yigit N, Covey S, Barouk-Fox S, Turker T, Geyer JT, Orazi A. Nuclear factor-erythroid 2, nerve growth factor receptor, and CD34-microvessel density are differentially expressed in primary myelofibrosis, polycythemia vera, and essential thrombocythemia. Hum Pathol. 2015;46(8):1217-25.

Labbé DP, Zadra G, Ebot EM, Mucci LA, Kantoff PW, Loda M, et al. Role of diet in prostate cancer: the epigenetic link. Oncogene. 2015;34(36):4683-91.

Rabadan R, Inghirami G. JAK-STAT in lymphoproliferative disorders. Oncoscience. 2015;2(9):737-8.

Wilhelmus S, Alpers CE, H Cook T, Ferrario F, Fogo AB, Haas M, et al. The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions. J Am Soc Nephrol. 2015;26(12):2938-46.

Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson S-, et al. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Mol Cancer Res. 2015;13(10):1431-40.

Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, et al. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer. Prostate. 2015;75(9):897-906.

Farooqui M, Bohrer LR, Brady NJ, Chuntova P, Kemp SE, C Wardwell T, et al. Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival. Mol Cancer. 2015;14:138.

Westblade LF, Ranganath S, Dunne WM, Burnham C-, Fader R, Ford BA. Infection with a chlorophyllic eukaryote after a traumatic freshwater injury. N Engl J Med. 2015;372(10):982-4.